2025 Volume 51 - Canada Communicable Disease Report (CCDR)
Submit a manuscript
About CCDR
Browse
ISSN: 1481-8531
2025 Volume 51
CCDR Volume 51-10/11/12, October/November/December 2025: Tuberculosis and Migration in Canada
- Summary of the National Advisory Committee on Immunization (NACI) Statement: Recommendations on the use of pneumococcal vaccines in adults, including Pneu-C-21
- Evaluating Canada’s initiative of enhanced screening for tuberculosis infection in migrants: Implementation lessons from Alberta
- Treatment of tuberculosis infection among immigrants in southern New Brunswick, Canada: A cross-sectional study
- Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2024
- Trust in community as a predictor of public health measure adherence: Insights from a national Canadian survey
- Detection of non-travel-associated, ceftriaxone non-susceptible Neisseria gonorrhoeae FC428-like harbouring the mosaic penA60 allele in Ontario, Canada
- Zoonoses
CCDR Volume 51-9, September 2025: Implementation Science in Public Health
- Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026
- Does influenza vaccination contribute to the prevention of cardiovascular events? An umbrella review
- Minimum data cleaning recommendations for infection prevention and control acute care surveillance reporting: A solution for “garbage in, garbage out”
- The innovative and purpose-built veterinary antimicrobials sales reporting system
- First reported Canadian case of Trichophyton mentagrophytes genotype VII infection among men who have sex with men (MSM)
- Estimating the population size of people who inject drugs in Canada, 2021
- Travel-related dengue, Zika and chikungunya in Canada, 2024: Update to results from a feasibility pilot study on laboratory-based surveillance
CCDR Volume 51-8, August 2025: Antiviral Therapy
- Summary of the National Advisory Committee on Immunization (NACI) statement on the prevention of respiratory syncytial virus (RSV) in older adults
- Evaluation of a real-time hospital surveillance system for respiratory syncytial virus, Ontario, Canada, 2022–2023
- Implementation of the COVID-19 antiviral therapy Nirmatrelvir/Ritonavir (PaxlovidTM) across Canada in 2022: A qualitative analysis of key facilitating factors and challenges
- Effectiveness of the four-component protein-based meningococcal vaccine against Neisseria gonorrhoeae infections: Mounting evidence and public health implications for Canada
- Safety monitoring of Imvamune vaccine during the 2022 mpox outbreak in Canada
CCDR Volume 51-6/7, June/July 2025: Hepatitis B & C Viruses in Canada
- Estimated prevalence of hepatitis B and C among immigrants in Canada
- National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concern
- Prevalence and awareness of hepatitis B and hepatitis C and vaccine-induced immunity to hepatitis B: Findings from the Canadian Health Measure Survey, 2016–2019
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2019–2023
- Device and surgical procedure-related infections in Canadian acute care hospitals, 2019–2023
- Ten years of Foodbook: Utilization of Foodbook survey data for research
CCDR Volume 51-5, May 2025: Travel Health
- A Science Strategy for the Public Health Agency of Canada
- Assessing the impact of the COVID-19 pandemic on trends of select travel-acquired enteric illnesses in Canada
- Enhanced screening for tuberculosis infection among immigrants in southern New Brunswick: A cross-sectional pilot study
- Cutaneous larva migrans in Canadian travellers returning from the Caribbean: A 10-year surveillance analysis from CanTravNet
- Acute histoplasmosis in four immunocompetent Canadian travellers to a cenote in Yucatán, Mexico
- Proposed approaches for public health surveillance: A literature review for the Canadian National HIV Surveillance Program
- Travel-related dengue, Zika and chikungunya in Canada, 2012–2023: Results from a feasibility pilot study on laboratory-based surveillance
- Retro 3: A feasibility pilot study for the development of a laboratory-based surveillance system for vector-borne diseases
CCDR Volume 51-4, April 2025: Challenges in Managing Gonorrhea and Prevention
- Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in Infants
- Environmental scan of available guidelines for chlamydia and gonorrhea screening recommendations for non-pregnant adolescents/adults in developed countries
- Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2022
- A rapid review of the avian influenza PB2 E627K mutation in human infection studies
- Associations between self-reported SARS-CoV-2 infection status, serology and common longer-term COVID-19 symptoms among adults in Canada, a cross-sectional study
- Screening of retail milk in Ontario for the presence of influenza A viral RNA
- Tips for Safely Handling Backyard Flock Eggs
CCDR Volume 51-2/3, February/March 2025: Health Economics in Public Health
- Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison
- Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: a cost-utility analysis
- Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations
- Public Health Risks Associated with Dog Importation
- Summary of the mpox outbreak in Canada, April 28−December 31, 2022
- Differences in sensationalism in international news media reporting of COVID-19: An exploratory analysis using the Global Public Health Intelligence Network (GPHIN) system
- Infectious syphilis and congenital syphilis in Canada, 2023
CCDR Volume 51-1, January 2025: Personal Protective Measures
- Summary of the National Advisory Committee on Immunization (NACI) Statement—Updated guidance on Imvamune in the context of a routine immunization program
- Is there sufficient evidence to inform personal protective equipment choices for healthcare workers caring for patients with viral hemorrhagic fevers?
- Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023
- Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection
- The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018–2021
- Using behavioural science to improve antibiotic stewardship in Canadian long-term care homes: Protocol for a multi-center cluster randomized quality improvement study